Market News Archive
Stay updated with the latest announcements
SEMLIBBLSF: Q3 Financials
(Q3 Un-audited): EPU was Tk. 0.21 for January-March 2026 as against Tk. (0.09) for January-March 2025; EPU was Tk. 0.16 for July 2025-March 2026 as against Tk. 0.31 for July 2024-March 2025. NOCFPU was Tk. 0.37 for July 2025-March 2026 as against Tk. 0.37 for July 2024-March 2025. NAV per unit at market price was Tk. 9.67 as on March 31, 2026 and Tk. 9.51 as on June 30, 2025. NAV per unit at cost price was Tk. 11.75 as on March 31, 2026 and Tk. 11.47 as on June 30, 2025.
KDSALTD: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.52 for January-March 2026 as against Tk. 0.51 for January-March 2025; EPS was Tk. 1.52 for July 2025-March 2026 as against Tk. 1.56 for July 2024-March 2025. NOCFPS was Tk. (0.96) for July 2025-March 2026 as against Tk. 3.30 for July 2024-March 2025. NAV per share was Tk. 28.23 as on March 31, 2026 and Tk. 27.71 as on June 30, 2025. (cont.1)
SILCOPHL: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.05 for January-March 2026 as against Tk. 0.13 for January-March 2025; EPS was Tk. 0.32 for July 2025-March 2026 as against Tk. 0.40 for July 2024-March 2025. NOCFPS was Tk. 0.67 for July 2025-March 2026 as against Tk. 0.71 for July 2024-March 2025. NAV per share was Tk. 23.27 as on March 31, 2026 and Tk. 23.02 as on June 30, 2025.
1STPRIMFMF: Q1 Financials
(Q1 Un-audited): EPU was Tk. 0.49 for January-March 2026 as against Tk. 0.68 for January-March 2025. NOCFPU was Tk. (1.73) for January-March 2026 as against Tk. 0.11 for January-March 2025. NAV per unit at market price was Tk. 9.08 as on March 31, 2026 and Tk. 8.59 as on December 31, 2025. NAV per unit at cost price was Tk. 15.00 as on March 31, 2026 and Tk. 16.74 as on December 31, 2025.
FEKDIL: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.08) for January-March 2026 as against Tk. 0.72 for January-March 2025; EPS was Tk. (0.99) for July 2025-March 2026 as against Tk. 1.45 for July 2024-March 2025. NOCFPS was Tk. (2.01) for July 2025-March 2026 as against Tk. (0.03) for July 2024-March 2025. NAV per share was Tk. 19.23 as on March 31, 2026 and Tk. 21.37 as on June 30, 2025. (cont.)
AMBEEPHA: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.40 for January-March 2026 as against Tk. 0.85 for January-March 2025; EPS was Tk. 2.26 for July 2025-March 2026 as against Tk. 2.17 for July 2024-March 2025. NOCFPS was Tk. (22.41) for July 2025-March 2026 as against Tk. (5.69) for July 2024-March 2025. NAV per share was Tk. 14.73 as on March 31, 2026 and Tk. 13.47 as on June 30, 2025.
CENTRALPHL: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.09) for January-March 2026 as against Tk. (0.10) for January-March 2025; EPS was Tk. (0.23) for July 2025-March 2026 as against Tk. (0.24) for July 2024-March 2025. NOCFPS was Tk. (0.01) for July 2025-March 2026 as against Tk. (0.00) for July 2024-March 2025. NAV per share was Tk. 6.64 as on March 31, 2026 and Tk. 6.87 as on June 30, 2025.
KBPPWBIL: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.21 for January-March 2026 as against Tk. 0.08 for January-March 2025; EPS was Tk. 0.57 for July 2025-March 2026 as against Tk. 0.15 for July 2024-March 2025. NOCFPS was Tk. 0.80 for July 2025-March 2026 as against Tk. 0.08 for July 2024-March 2025. NAV per share was Tk. 12.02 as on March 31, 2026 and Tk. 12.07 as on June 30, 2025.
SQURPHARMA: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 6.73 for January-March 2026 as against Tk. 6.83 for January-March 2025; Consolidated EPS was Tk. 23.29 for July 2025-March 2026 as against Tk. 21.15 for July 2024-March 2025. Consolidated NOCFPS was Tk. 17.54 for July 2025-March 2026 as against Tk. 11.90 for July 2024-March 2025. Consolidated NAV per share was Tk. 169.79 as on March 31, 2026 and Tk. 157.88 as on June 30, 2025. (cont.)
RAHIMTEXT: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.25 for January-March 2026 as against Tk. 0.30 for January-March 2025; EPS was Tk. 2.06 for July 2025-March 2026 as against Tk. 0.80 for July 2024-March 2025. NOCFPS was Tk. 16.02 for July 2025-March 2026 as against Tk. 32.10 for July 2024-March 2025. NAV per share was Tk. 27.60 as on March 31, 2026 and Tk. 25.83 as on June 30, 2025. (cont.)
MITHUNKNIT: Q3 Financials
(Q3 Un-audited): The Company informed that due to suspension of factory operation, the Earnings Per Share and Net Operating Cash Flow Per share were null. The company has further informed that it is not possible to disclose the Net Asset value (NAV) of the Company before a final report of the enquiry committee recommended by BSEC has been submitted.
TALLUSPIN: Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.90) for January-March 2026 as against Tk. (0.96) for January-March 2025; EPS was Tk. (1.96) for July 2025-March 2026 as against Tk. (1.43) for July 2024-March 2025. NOCFPS was Tk. 0.008 for July 2025-March 2026 as against Tk. 0.01 for July 2024-March 2025. NAV per share was Tk. 11.38 as on March 31, 2026, and Tk. 13.34 as on June 30, 2025.
BARKAPOWER: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 0.76 for January-March 2026 as against Tk. 0.26 for January-March 2025; Consolidated EPS was Tk. 0.87 for July 2025-March 2026 as against Tk. 0.29 for July 2024-March 2025. Consolidated NOCFPS was Tk. (0.40) for July 2025-March 2026 as against Tk. 4.37 for July 2024-March 2025. Consolidated NAV per share was Tk. 23.50 as on March 31, 2026, and Tk. 22.63 as on June 30, 2025. (cont.)
BANKASIA: Board approves increase of Authorized Capital
The Authorized Capital of the Company will be increased from 15,000,000,000.00 (Taka one thousand five hundred crore) divided into 1,500,000,000 (one hundred fifty crore) ordinary shares of Tk. 10.00 each to Tk. 30,000,000,000.00 (Taka three thousand crore) only divided into 3,000,000,000 (three hundred crore) ordinary shares of Tk. 10.00 each subject to the approval from Bangladesh Bank, and the adoption of Special Resolution by the Shareholders of the Company at the General Meeting.
BANKASIA: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.04.2026) following its corporate declaration.
BANKASIA: Dividend Declaration
The Board of Directors has recommended 8.50% Cash Dividend and 8.50% Stock Dividend for the year ended December 31, 2025. Date of AGM: June 11, 2026, Time: 11:00 a.m., Venue/Mode: Through Digital Platform (link will be communicated in due course), Record Date: May 20, 2026. (cont. 1)
MTB: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.04.2026) following its corporate declaration.
MTB: Dividend Declaration
The Board of Directors has recommended 12% Stock Dividend for the year ended December 31, 2025, subject to approval by the respective regulatory authorities and the shareholders at the 27th Annual General Meeting (AGM). Date of AGM: June 28, 2026, Time: 11.30 a.m., Venue/Mode: Virtual Meeting, Record Date: May 20, 2026. (cont.1)
TECHNODRUG: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.31 for January-March 2026 as against Tk. 0.33 for January-March 2025; EPS was Tk. 1.18 for July 2025-March 2026 as against Tk. 1.41 for July 2024-March 2025. NOCFPS was Tk. 1.62 for July 2025-March 2026 as against Tk. 0.15 for July 2024-March 2025. NAV per share with revaluation was Tk. 31.38 as on March 31, 2026, and Tk. 30.58 as on June 30, 2025. NAV per share without revaluation was Tk. 27.69 as on March 31, 2026, and Tk. 26.88 as on June 30, 2025. (cont.)
UPGDCL: Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 4.69 for January-March 2026 as against Tk. 7.21 for January-March 2025; Consolidated EPS was Tk. 14.69 for July 2025-March 2026 as against Tk. 19.32 for July 2024-March 2025. Consolidated NOCFPS was Tk. 7.22 for July 2025-March 2026 as against Tk. 15.17 for July 2024-March 2025. Consolidated NAV per share was Tk. 82.08 as on March 31, 2026, and Tk. 73.89 as on June 30, 2025. (Cont.)